Published recall report · Quality failureUpdated · 6 days ago
Ajanta Pharma USA Inc recall: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
- Producer
- Ajanta Pharma USA Inc
- Brand
- RANOLAZINE
DJ25134
- Dates on pack
- Lot: DJ25134, Exp 11/30/2028
0327241125027
0327241126024
More detail
Failed Dissolution Specifications: below specification
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.